Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan; Division of Digestive and Liver Disease, Department of Medicine, Columbia University, New York, New York.
Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Gastroenterology. 2019 Mar;156(4):1066-1081.e16. doi: 10.1053/j.gastro.2018.11.024. Epub 2018 Nov 15.
BACKGROUND & AIMS: The intestinal epithelium is maintained by long-lived intestinal stem cells (ISCs) that reside near the crypt base. Above the ISC zone, there are short-lived progenitors that normally give rise to lineage-specific differentiated cell types but can dedifferentiate into ISCs in certain circumstances. However, the role of epithelial dedifferentiation in cancer development has not been fully elucidated. METHODS: We performed studies with Bhlha15-CreERT, Lgr5-DTR-GFP, Apc, LSL-Notch (IC), and R26-reporter strains of mice. Some mice were given diphtheria toxin to ablate Lgr5-positive cells, were irradiated, or were given 5-fluorouracil, hydroxyurea, doxorubicin, or dextran sodium sulfate to induce intestinal or colonic tissue injury. In intestinal tissues, we analyzed the fate of progeny that expressed Bhlha15. We used microarrays and reverse-transcription PCR to analyze gene expression patterns in healthy and injured intestinal tissues and in tumors. We analyzed gene expression patterns in human colorectal tumors using The Cancer Genome Atlas data set. RESULTS: Bhlha15 identified Paneth cells and short-lived secretory precursors (including pre-Paneth label-retaining cells) located just above the ISC zone in the intestinal epithelium. Bhlha15 cells had no plasticity after loss of Lgr5-positive cells or irradiation. However, Bhlha15 secretory precursors started to supply the enterocyte lineage after doxorubicin-induced epithelial injury in a Notch-dependent manner. Sustained activation of Notch converts Bhlha15 secretory precursors to long-lived enterocyte progenitors. Administration of doxorubicin and expression of an activated form of Notch resulted in a gene expression pattern associated with enterocyte progenitors, whereas only sustained activation of Notch altered gene expression patterns in Bhlha15 precursors toward those of ISCs. Bhlha15 enterocyte progenitors with sustained activation of Notch formed intestinal tumors with serrated features in mice with disruption of Apc. In the colon, Bhlha15 marked secretory precursors that became stem-like, cancer-initiating cells after dextran sodium sulfate-induced injury, via activation of Src and YAP signaling. In analyses of human colorectal tumors, we associated activation of Notch with chromosome instability-type tumors with serrated features in the left colon. CONCLUSIONS: In mice, we found that short-lived precursors can undergo permanent reprogramming by activation of Notch and YAP signaling. These cells could mediate tumor formation in addition to traditional ISCs.
背景与目的:肠道上皮由位于隐窝底部附近的长寿肠干细胞(ISC)维持。在 ISC 区上方,有短暂寿命的祖细胞,它们通常分化为谱系特异性的分化细胞类型,但在某些情况下可以去分化为 ISC。然而,上皮去分化在癌症发展中的作用尚未完全阐明。
方法:我们使用了 Bhlha15-CreERT、Lgr5-DTR-GFP、Apc、LSL-Notch(IC)和 R26-报告基因的小鼠进行了研究。一些小鼠接受白喉毒素以消除 Lgr5 阳性细胞,接受辐射,或接受 5-氟尿嘧啶、羟基脲、阿霉素或葡聚糖硫酸钠以诱导肠道或结肠组织损伤。在肠道组织中,我们分析了表达 Bhlha15 的后代的命运。我们使用微阵列和逆转录 PCR 分析健康和损伤的肠道组织以及肿瘤中的基因表达模式。我们使用癌症基因组图谱数据集分析了人类结直肠肿瘤中的基因表达模式。
结果:Bhlha15 鉴定了 Paneth 细胞和位于 ISC 区上方的短暂分泌前体细胞(包括前 Paneth 标记保留细胞)。在 Lgr5 阳性细胞缺失或辐射后,Bhlha15 细胞没有可塑性。然而,在阿霉素诱导的上皮损伤后,Bhlha15 分泌前体细胞开始以 Notch 依赖性方式供应肠细胞谱系。持续激活 Notch 将 Bhlha15 分泌前体细胞转化为长寿肠祖细胞。阿霉素的给药和 Notch 激活形式的表达导致与肠祖细胞相关的基因表达模式,而仅持续激活 Notch 会使 Bhlha15 前体细胞的基因表达模式向 ISC 转变。具有持续激活 Notch 的 Bhlha15 肠祖细胞在 APC 破坏的小鼠中形成具有锯齿状特征的肠道肿瘤。在结肠中,Bhlha15 标记的分泌前体细胞在葡聚糖硫酸钠诱导的损伤后通过激活Src 和 YAP 信号成为类似干细胞的起始细胞。在对人类结直肠肿瘤的分析中,我们发现 Notch 的激活与左结肠锯齿状特征的染色体不稳定型肿瘤相关。
结论:在小鼠中,我们发现短暂寿命的前体细胞可以通过 Notch 和 YAP 信号的激活进行永久重编程。这些细胞除了传统的 ISC 外,还可以介导肿瘤形成。
Gastroenterology. 2018-11-15
Proc Natl Acad Sci U S A. 2016-9-13
Gastroenterology. 2020-9
Cell Mol Gastroenterol Hepatol. 2018-11-27
Am J Physiol Gastrointest Liver Physiol. 2017-6-1
Gastroenterology. 2020-1-11
Gastroenterology. 2012-2-11
Cell Mol Gastroenterol Hepatol. 2025
Invest Ophthalmol Vis Sci. 2024-4-1
Am J Physiol Gastrointest Liver Physiol. 2023-12-1
Stem Cell Rev Rep. 2023-10
Cell Stem Cell. 2018-6-7
Am J Physiol Gastrointest Liver Physiol. 2018-1-18
Cell Stem Cell. 2017-12-14
Nature. 2017-11-16
Am J Physiol Gastrointest Liver Physiol. 2017-10-1